HEADLINES: • BIM: 4Q25 results – strong beat POSITIVE • Enea: preliminary 4Q25 EBITDA 25% below expectations on Supply one-offs; adjusted EBITDA 2% below forecast NEUTRAL • Enea / Tauron: URE orders additional payments to the Price Difference Payment Fund NEUTRAL • PGE: completes acquisition of 350 MW Bałtyk II offshore wind project from RWE NEUTRAL • Warsaw Stock Exchange: PLN 10.7m impairment losses to spoil otherwise strong quarter (due on 23 March) NEGATIVE • Footshop: preliminary 4Q25 resul...
GEVORKYAN has posted a weak set of 4Q25 results, with the EBITDA 23% below our estimate, driven by softer revenue growth and a weaker other operating result. The net profit was negative, at -EUR 1.5m, reflecting higher-than-anticipated D&A and a lower net financial result. For full-year 2025, the company’s EBITDA missed the low end of its 2025 guidance by 6%, although it has reiterated its mid-term (2026-29E) guidance.
HEADLINES: • Grupa Pracuj: valuation harmed unjustly by AI threat (stays BUY) • Inter Cars: February sales up by 11% yoy POSITIVE • Zabka: 4Q25E results preview – 12% yoy EBITDA growth expected (due on 19 March) NEUTRAL • MOL: Hungary to cap fuel pump prices NEGATIVE • Sok Marketler: recovery in operating results continued in 4Q25 POSITIVE • GEVORKYAN: preliminary 4Q25 miss on P&L lines; 2025 below the lower end of management's guidance, tight balance sheet NEGATIVE
EME Equity Market – February 2026 Muted performance across the region, with the Turkish ISE the best performer. The MSCI EM Europe Index declined by 0.7% mom in EUR terms and 2.1% mom in USD terms in February. The Turkish ISE was the top performer, adding 5.4% mom in EUR terms; while the Polish WIG and the Romanian BET improved slightly (+0.9% and +0.3% mom, respectively, in EUR terms). The Czech PX and the Greek ASE were the worst performers (-4.9%, and -3.0% mom, respectively, in EUR terms), w...
HEADLINES: • Turkish food retailers: resilient in transition (BIM and Migros stay BUY, Sok Marketler stays HOLD) • Budimex: 4Q25 preliminary results in line with the January guidance NEUTRAL • Allegro: 4Q25E results preview – adjusted EBITDA expected to grow by 13% yoy (due on 12 March) NEUTRAL • Hungary macro: MNB delivers long-awaited rate cut • Richter: 4Q25E preview (due on 27 February) NEUTRAL • NEPI Rockcastle: 2H25 results at the top of the guided range NEUTRAL • Banca Transilvania: 4Q25E...
HEADLINES: • Poland macro: NBP cuts again, with inflation back at target • Wirtualna Polska: sells Invia Flights Germany at EUR 42.3m EV, 9.0x 2024 EV/EBITDA POSITIVE • WOOD's Winter Wonderland EME Conference 2025: Postcards from Prague • Allegro • Asseco Poland • Benefit Systems • Budimex • CCC • Kety • PGE • Tauron • Primoco UAV • Aquila Part Prod Com S.A. • MedLife • Mavi • Georgia Capital • GEVORKYAN • Krka • Medicover
EME Equity Market – November 2025 Czech PX leads in November, Türkiye the only loser. The MSCI EM Europe Index added 1.5% mom in EUR terms and 2.1% mom in USD terms in November. The Czech PX was the top performer, adding 4.7% mom in EUR terms, followed by the Greek ASE and the Hungarian BUX (+4.4% and +3.7% mom, respectively, in EUR terms). The Romanian BET and Polish WIG 20 were also in the green (+1.3% and +1.0% mom in EUR terms). The only loser was the Turkish ISE 30 (-2.0% mom in EUR terms).
HEADLINES: • OTE: multiple tailwinds supporting the equity story (stays BUY) • PZU: very strong 3Q25 bottom line, strong beat vs. expectations, but slower revenue growth raises questions for the future POSITIVE • Allegro: 3Q25 above expectations; FY25E guidance trimmed due to slower November NEUTRAL • Cyfrowy Polsat: 3Q25 results review – adjusted EBITDA down 12% yoy, in line with the consensus NEUTRAL • Grupa Pracuj: 3Q25 results – adjusted EBITDA up 3% yoy, 2% above our forecast and 11% above ...
GEVORKYAN’s 3Q25 results were mixed, with an EBITDA beat, driven by higher-than-anticipated D&A expenses, but a miss on the net profit line, due to higher tax and a lower net financial result. The company has kept both its 2025E and long-term (2025-29E) guidance unchanged. While there is some upside risk for our EBITDA estimates, on the FCFF, we see the downside risk increasing, due to the higher capex that the company has announced for 2026E. Therefore, the FCFF turnaround point might be delaye...
EME Equity Market – October 2025 Hungarian BUX leads in October, Türkiye and Greece lag. The MSCI EM Europe Index added 3.5% mom in EUR terms and 1.8% mom in USD terms in October. The Hungarian BUX was the top performer, adding 9.1% mom in EUR terms; followed by the Polish WIG20 (+5.9% mom) and the Romanian BET (+5.4% mom) (in EUR terms). The Czech PX was also in the green (+2.8% mom in EUR terms). The Greek ASE and the Turkish ISE30 (-1.9% mom and -1.1% mom, in EUR terms, respectively) both los...
HEADLINES: • Santander Bank Polska: solid 3Q25 bottom line, but waiting for a change of strategic investor NEUTRAL • Alior Bank: 3Q25 results do not bring much to the table NEUTRAL • Zabka: 3Q25 a notch above the consensus POSITIVE • DataWalk: preliminary 3Q25 results – sales up 59% yoy, to PLN 7.34m POSITIVE • OMV: 3Q25 results – CCS EBITDA above estimates POSITIVE • OMV Petrom: 3Q25 results – net income beat NEUTRAL • Borouge: 3Q25 results – broadly in line NEUTRAL • Solutions by STC: 3Q25 fin...
EME Equity Market – September 2025 Romanian BET led in September, while Türkiye and Hungary lagged. The MSCI EM Europe Index added 0.7% mom in EUR terms and 1.1% in USD terms. The Romanian BET was the top performer, adding 3.6% in EUR terms; followed by the Czech PX (+3.2% mom) and the Polish WIG20 (+1.1% mom) (all in EUR terms); while there was a muted performance from the Greek ASE (+0.6% mom in EUR terms). The Turkish ISE30 and the Hungarian BUX were the worst performing indices in September(...
HEADLINES: • Allegro: 1Q25 results spot on our expectations; lower bound of FY25E guidance increased POSITIVE • Colt CZ Group: 2Q25 results – slightly below the consensus; no changes in FY25E guidance • Mavi: 2Q25 results miss expectations; 2025E guidance lowered NEGATIVE • Echo Investment: 2Q25 – sales could unlock net cash equivalent to one-third of market cap • Auto Partner: 2Q25 EBITDA broadly in line with our and the market's expectations NEUTRAL • Lamda Development: 2Q25 – yield compressio...
GEVORKYAN’s 2Q25 results were broadly in line with our estimates, and the company has upgraded both its 2025E and long-term (2025-29E) guidance. For 2025E, at the midpoint, the new guidance implies a 5% increase in revenues and a 15% increase in the EBITDA vs. the previous (May) guidance. For the mid-term, our 2025-27E estimates remain in line with the bottom end of GEVORKYAN’s guidance; however, if executed successfully, it could provide additional upside for our forecasts. Importantly, the upg...
EME Equity Market – August 2025 Corrections in Poland and the broader MSCI EM Europe. The MSCI EM Europe Index declined by 2.3% mom in EUR terms and was flat (0.0%) in USD terms in August. The Hungarian BUX was the top performer, adding 2.2% mom in EUR terms, followed by the Romanian BET (+1.9% mom), the Czech PX (+1.7% mom) and the Greek ASE (+1.4% mom) (all in EUR terms); while there was a muted performance from the Turkish ISE 30 (+0.4% mom in EUR terms). The biggest loser was the Polish WIG ...
HEADLINES: • Warsaw Stock Exchange: bottom-line beat in 2Q25, due mostly to non-operating net revenues POSITIVE • KazMunayGas: 2Q25 results – EBITDA in line with our forecast NEUTRAL • Cyfrowy Polsat: 2Q25 results review – adjusted EBITDA down 2% yoy, in line with the consensus NEUTRAL • Mo-BRUK: 2Q25 EBITDA up 6% yoy, in line with our and the market's expectations NEUTRAL • Orlen: 2Q25 results – broadly in line NEUTRAL • Lion Finance Group: 2Q25 highlights – in line, but not strong enough to sh...
EME Equity Market – June 2025 All EME indices in the green in June, with a rebound in Türkiye. The MSCI EM Europe Index advanced by 3.2% mom in EUR terms and 6.9% in USD terms. The Turkish ISE 30 Index was the best performer in our region, recouping the losses from the previous month and adding +6.6% mom in EUR terms. The Hungarian BUX and the Polish WIG indices added 3.1% and 2.8% mom in EUR terms, respectively, followed closely by the Romanian BET and the Greek ASE, with both adding 2.0% mom i...
HEADLINES: • EME Macro/Strategy: macro all-in-one (16-22 June) • Turkish Airlines: confirms talks over Air Europa stake purchase NEUTRAL • Aegean Airlines: may issue EUR 200-250m of new bonds NEUTRAL • GEVORKYAN: might raise up to 3.5m shares in the next 5Y NEUTRAL • EME Strategy: MSCI 2025 Global Market Accessibility Review
We have downgraded GEVORKYAN to HOLD (from Buy), with a new 12M price target (PT) of CZK 257/share, implying 11% upside. The share price is 6% below its July 2022 IPO price. We believe the relatively high IPO valuation (12.6x EV/EBITDA) and the prolonged capex cycle are the key reasons for the rerating of the stock closer to its CEE industrial peers. While the capex cycle has enabled GEVORKYAN to expand capacity, buy high-end machinery and sign a record number of contracts, it is still not over....
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.